The novel coronavirus pneumonia is an acute infectious disease caused by infection with SARS-CoV-2. The disease presents obvious population aggregation, mainly family aggregation. Current epidemiological investigations show that the incubation period is generally 3 - 7 days, rarely more than 14 days. The elderly and those with underlying diseases are more seriously ill after infection, leading to severe pneumonia and even death. Adults can be diagnosed with severe pneumonia if they meet any of the following criteria: (1) shortness of breath (RR ≥ 30/min); (2) at rest, oxygen saturation ≤ 93%; (3) arterial partial oxygen pressure (PaO
2)/oxygen absorption concentration (FiO
2) ≤ 300 mmHg (1 mmHg = 0.133 kpa); (4) pulmonary imaging shows that the lesion progresses more than 50% within 24 to 48 hours (
5). Young people tend to have milder symptoms, and children and infants can also develop the disease. Recent reports (
6,
7) have shown that, the disease tends to occur in men, and the clinical manifestations are mainly fever and dry cough, and some patients may have diarrhea and vomiting. In our study, there were slightly more male patients, and the main symptoms of most COVID-19 patients were fever, cough, and sputum, which is more common in elderly patients.
In this study, there was no significant difference in the distribution of time intervals from disease onset to CT examination between elderly patients and young patients. The interference of different imaging manifestations caused by the course of disease was excluded. Elderly COVID-19 patients are associated with a variety of basic diseases, such as hypertension, and diabetes. Their clinical symptoms are relatively more complex than those of young people. Some studies have shown that the serum antibody concentration of the elderly is reduced and the antibody response to the disease is lower than that of the young. Immune decline and immune aging make elderly COVID-19 patients more serious after infection. Disease progression is faster than young people and easy to develop into severe or critical patients, accounting for a high proportion of patients with severe pneumonia and leading to an increase in case fatality. In terms of imaging findings, chest CT of elderly COVID-19 patients was characterized by mixed ground-glass opacification and consolidation, and their lesions were always in the dynamic change and severe pneumonia in the majority, while the majority of lesions were ground-glass opacification in the group of young patients, and pulmonary consolidation is more common in elderly patients. This may indicate that elderly patients show a more severe inflammatory response and deterioration of lung structure.
Thin-section CT scan of the chest is especially important for early clinical screening, disease evaluation and efficacy follow-up of COVID-19 patients, and has become a required test item for clinical diagnosis (
8,
9). Chest CT is mainly characterized by ground-glass opacities and consolidation (
10). In the early stage, it is mainly manifested as the patchy ground-glass opacities in the lung, which is mostly distributed in the outer lung zone and under the pleura, and is common in the middle and lower lung lobes. In the progressive stage, multiple ground-glass opacities and consolidation can be seen in both lungs, which can cause grid-like changes and show crazy paving pattern. In some lesions, vascular shadow crossing and air bronchogram can be seen. In the critical stage, the lesions were diffuse (presence of extensive involvement of bilateral lung lobes, ground-glass opacity and ground-glass opacity with consolidation) and even presented as white lung, with bilateral pleural thickening. Pleural effusion and mediastinal lymphadenopathies are rare (
11). The imaging findings of COVID-19 are similar to those of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) (
12,
13). These chest CT findings were mostly distributed in the peripheral bilateral lung field and the subpleural area, probably because the virus mainly affects the terminal bronchioles and lung parenchyma around the respiratory bronchioles in the early stage, which is consistent with the current report (
14,
15). Some patients also had crazy paving pattern, air bronchogram, bronchiolectasis, pleural effusion, lymphadenopathies, thickening of the adjacent pleura and atelectasis, which are slightly more common among the elderly. The main differential diagnosis of COVID-19 includes mycoplasma pneumonia, cytomegalovirus pneumonia, SARS, MERS and other viral pneumonia.
CT images of COVID-19 patients have comparatively characteristic manifestations. Familiarity with these findings can help us to accurately diagnose COVID-19 pneumonia in different age groups. A small percentage of young people have no clinical symptoms and only imaging findings. Hence, chest thin-section CT scan is particularly important in screening asymptomatic patients with infection. There is a certain false negative rate in RT-PCR test. Some patients who are finally diagnosed as COVID-19 have negative nucleic acid tests in pharynx swabs while their CT scans have characteristic pneumonia manifestations (
16). CT should be used as the main imaging method for diagnosis on the basis of nucleic acid detection combined with clinical manifestations and epidemiological history. Familiarity with these will facilitate early diagnosis of COVID-19 and timely isolation of patients, guide treatment and assess efficacy, and contain the spread of the epidemic. Due to the small sample size and short time in this study, CT images of the entire treatment process of COVID-19 patients were not analyzed, which needs to be further studied in future clinical work.
In conclusion, pulmonary coexistence of ground-glass opacities and consolidation are relatively common in the elderly patients. Existence of underlying diseases in these patients tends to increase the possibility of developing into severe pneumonia. However, ground-glass opacification is more common in young patients. The proportion of extensive involvement of lung lobes was higher in the elderly group compared to the young group. It can be seen from the difference that the clinical symptoms and imaging manifestations of the elderly are more serious, indicating that old age, male sex and complications may be important factors affecting the severity and therapeutic effect of COVID-19 patients.